Dermaliq Therapeutics

Dermaliq Therapeutics, Inc. is a newly established Delaware-based specialty pharmaceutical company spun off from Germany's Novaliq GmbH. Dermaliq is developing next-generation skincare therapies to enhance targeted penetration into skin tissues and reduce adverse side effects for millions of patients. It is leveraging its groundbreaking hyliQ® technology platform to develop and commercialize next-generation drugs, benefiting patients with unmet dermatological medical needs.